Results 71 to 80 of about 28,384 (222)
The left atrial appendage in health and disease
Atrial fibrillation (AF) is the commonest sustained cardiac arrhythmiaand results in significant morbidity and mortality. The left atrial appendage (LAA), a small embryonic remnant of the left atrium (LA), has been shown to play a key role in the ...
Howlett, Philippa J. +2 more
core +1 more source
Abstract Secondary aortoduodenal fistula (sADF) is a rare but life‐threatening complication after aortic graft surgery. Diagnosis is often challenging, particularly when contrast‐enhanced computed tomography (CT) and endoscopy results are inconclusive. We report a case in which diagnosis was challenging due to contrast media allergy and non‐diagnostic ...
Jun Kubota +6 more
wiley +1 more source
Left Atrial Appendage Occlusion
Mohamad Alkhouli +5 more
+5 more sources
Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens
Real‐world edoxaban concentrations in older patients receiving reduced‐dose regimens. Low trough concentrations (< 12 ng/mL) were associated with an increased risk of thromboembolism. Among patients meeting the ELDERCARE‐AF criteria, low drug levels were more frequent with the 15 mg regimen than with the 30 mg regimen.
Sung‐Chun Tang +8 more
wiley +1 more source
Effects of Endocardial Microwave Energy Ablation [PDF]
Until recently the treatment of atrial fibrillation (AF) consisted primarily of palliation, mostly in the form of pharmacological intervention. However because of recent advances in nonpharmacologic therapies, the current expectation of patients and ...
Aquilino, Hurlé +3 more
core
Left atrial appendage occlusion: Percutaneous and surgical approaches in everyday practice.
Prophylactic left atrial appendage occlusion has been suggested as a means of cardioembolism risk reduction in patients with atrial fibrillation. Its clinical benefits have been discussed together with potential endocrine or hemodynamic adverse effects ...
Jan Gofus +5 more
semanticscholar +1 more source
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo +22 more
wiley +1 more source
Slow Conduction through an Arc of Block: A Basis for Arrhythmia Formation Post-Myocardial Infarction [PDF]
Introduction The electrophysiologic basis for characteristic rate-dependent, constant-late-coupled (390 + 54 milliseconds) premature ventricular beats (PVBs) present 4–5 days following coronary artery occlusion were examined in 108 anesthetized dogs.
Berbari, Edward J. +3 more
core +1 more source
A patient presenting with acute ischemic stroke associated with patent foramen ovale (PFO) had concurrent deep vein thrombosis, pulmonary embolism, and new‐onset atrial fibrillation.
Soban Ahmad, A. Goldsweig
semanticscholar +1 more source
In a prospective cohort of 226 young ischemic stroke survivors, medication persistence was high (80.1%) over a median 3.9‐year follow‐up, while adherence was moderate. Older age and large artery atherosclerosis predicted better adherence, whereas younger age and lower quality of life were associated with poor adherence.
Qiqi Wang +8 more
wiley +1 more source

